Perrigo OTC Pharmaceutical Sales Up More Than 20% In Third Quarter
This article was originally published in The Tan Sheet
Executive Summary
Perrigo OTC pharmaceutical sales jumped more than 20% in the fiscal third quarter ended April 3, the company reported May 11. However, on a year-to-date basis, the private labeler experienced only a modest increase in OTC sales, the company says in its 10-Q filing with the Securities & Exchange Commission.